首页> 美国卫生研究院文献>Oncotarget >Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses
【2h】

Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses

机译:在小鼠黑素瘤模型中使用CD25靶向的光动力疗法对调节性T细胞的肿瘤内耗竭诱导抗肿瘤免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor immunotherapy aims to overcome the immunosuppressive microenvironment within tumors, and various approaches have been developed. Tumor-associated T regulatory cells (Tregs) suppress the activation and expansion of tumor antigen-specific effector T cells, thus, providing a permissive environment for tumor growth. Therefore, optimal strategies need to be established to deplete tumor-infiltrated Tregs because systemic depletion of Tregs can result in reduced anti-tumor effector cells and autoimmunity. Here, to selectively deplete Tregs in tumors, we intratumorally injected anti-CD25 antibodies conjugated to Chlorin e6 (Ce6), a photosensitizer that absorbs light to generate reactive oxygen species. Local depletion of tumor-associated Tregs with photodynamic therapy (PDT) inhibited tumor growth, which was likely due to the altered tumor immune microenvironment that was characterized by increased infiltration of CD8+ effector T cells and the expression of IFN-γ and CD107a, which is a cytolytic granule exocytosis marker in tumor tissues. Furthermore, PDT-induced intratumoral Treg depletion did not influence adaptive immune responses in a murine influenza infection model. Thus, our results show that intratumoral Treg-targeted PDT could specifically modulate tumor microenvironments by depleting Tregs and could be used as a novel cancer immunotherapy technique.
机译:肿瘤免疫疗法旨在克服肿瘤内的免疫抑制微环境,并且已经开发出各种方法。肿瘤相关的T调节细胞(Tregs)抑制肿瘤抗原特异性效应T细胞的活化和扩增,从而为肿瘤的生长提供了一个宽松的环境。因此,需要建立最佳策略来消除肿瘤浸润的Treg,因为Treg的全身性消耗可导致抗肿瘤效应细胞减少和自身免疫性降低。在这里,为了选择性地消耗肿瘤​​中的Treg,我们在肿瘤内注射了与Chlorin e6(Ce6)结合的抗CD25抗体,后者是一种吸收光以产生活性氧的光敏剂。用光动力疗法(PDT)对肿瘤相关Treg的局部耗竭抑制了肿瘤的生长,这很可能是由于改变的肿瘤免疫微环境,其特征在于CD8 +效应T细胞的浸润增加以及IFN-γ和CD107a的表达。肿瘤组织中的溶细胞颗粒胞吐标记。此外,PDT诱导的肿瘤内Treg耗竭不影响鼠流感感染模型中的适应性免疫反应。因此,我们的结果表明,靶向Treg的肿瘤内PDT可以通过消耗Treg来特异性地调节肿瘤微环境,并且可以用作一种新型的癌症免疫治疗技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号